BlackRock Technology and Private Equity Term Trust (BTX)

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. TOP Financial Group Limited (NASDAQ: TOP) jumped 52.4% to close at $19.25. FlexShopper, Inc. (NASDAQ: FPAY) jumped 47.3% to close at $1.65 after reporting Q2 results. Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares gained 37.3% to close at $0.1483 on Thursday. Timber Pharmaceuticals recently announced closing of $8.0 million public offering. Veru Inc (NASDAQ: VERU) shares jumped 36% to close at $16.01 after the company reported Q3 earnings results. Nymox Pharmaceutical Corporation (NASDAQ: NYMX) jumped 35.6% to close at $0.61. Vacasa, Inc. (NASDAQ: VCSA) shares gained 33.2% to close at $4.05 after posting upbeat quarterly sales. AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) jumped 33% to close at $0.3126. The company on Wednesday announced acceptance for a podium presentation at the ANESTHESIOLOGY 2022 Annual Meeting. ShiftPixy, Inc. (NASDAQ: PIXY) gained 32.3% to close at $0.2620. Esports Entertainment Group, Inc. (NASDAQ: GMBL) shares gained 32% to close at $0.60 after Massachusetts Governor Baker on Wednesday signed a sports betting bill into law. PARTS iD, Inc. (NYSE: ID) gained 31.7% to close at $1.83. PARTS iD recently posted a Q2 loss of $0.03 per share. voxeljet AG (NASDAQ: VJET) jumped 31.3% to settle at $6.00. Enovix Corporation (NASDAQ: ENVX) climbed 30.8% to close at $21.13 following Q2 results. CASI Pharmaceuticals, Inc. (NASDAQ: CASI) jumped 29.6% to close at $3.90. CASI Pharmaceuticals is set to host a conference call reviewing the Q2 financial results on Friday, August 12th, 2022. Butterfly Network, Inc. (NYSE: BFLY) climbed 28.8% to settle at $8.61. UpHealth, Inc. (NYSE: UPH) jumped 28.8% to close at $0.89. Gamida Cell Ltd. (NASDAQ: GMDA) gained 28.4% to close at $3.39. Gamida Cell announced dosing of first patient in company-sponsored Phase 1/2 study of NK cell therapy candidate GDA-201. Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares jumped 26.3% to close at $1.68 after the company posted a narrower Q2 loss. T2 Biosystems, Inc. (NASDAQ: TTOO) shares climbed 26.3% to close at $0.1995. T2 Biosystems shares jumped over 30% on Wednesday after the company on Tuesday announced it will explore the potential to develop a rapid molecular diagnostic test for monkeypox. Humacyte, Inc. (NASDAQ: HUMA) gained 26.1% to settle at $4.40. 5E Advanced Materials Inc. (NASDAQ: FEAM) gained 25.6% to close at $19.72 after the company announced Bluescape will invest $60 million in 5E's secured convertible notes. SmileDirectClub, Inc. (NASDAQ: SDC) gained 24.6% to close at $1.62 as the stock reversed from weakness earlier in the week. The stock fell Monday after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates. Missfresh Limited (NASDAQ: MF) surged 24% to settle at $0.1976. Arhaus, Inc. (NASDAQ: ARHS) surged 23.9% to close at $7.93 after the company reported better-than-expected Q2 adjusted EPS and sales results and raised FY22 sales guidance above estimates. Midwest Holding Inc. (NASDAQ: MDWT) gained 23.7% to settle at $14.88. Dawson Geophysical Company (NASDAQ: DWSN) climbed 22.9% to close at $1.6350. Astra Space, Inc. (NASDAQ: ASTR) rose 22.7% to close at $1.73 after board member Michael Lehman reported a large insider buy on August 10 in a Form4 filing. Accuray Incorporated (NASDAQ: ARAY) jumped 21.1% to settle at $2.64 after the company reported better-than-expected Q4 EPS and sales results. SunOpta Inc. (NASDAQ: STKL) jumped 20.2% to close at $10.73. SunOpta raised its FY22 revenue guidance. Warby Parker Inc. (NYSE: WRBY) gained 19.2% to close at $16.90 after the company reported Q2 EPS results were higher year over year and better-than-expected Q2 sales results. AST SpaceMobile, Inc. (NASDAQ: ASTS) gained 18.7% to close at $10.87. AST SpaceMobile recently announced that its test satellite has arrived at the launch location for its upcoming planned launch. Quanterix Corporation (NASDAQ: QTRX) surged 18.7% to close at $10.16. Quanterix Director Paul Meister reported the purchase of 234,304 shares at an average price of $8.53 per share ...

SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused on developing advanced therapies using state-of-the-art mRNA cell engineering technology, today announced that on June 17, 2022, it received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company is not in compliance with the minimum bid price requirement ("Minimum Bid Requirement") of US$1.00 per share under the Nasdaq Listing Rule 5450(a)(1) based upon the closing bid price of the Company’s common stock for the 30 consecutive business days prior to the date of the Notice. The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.

The biotech is bulking up with a new acquisition.

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.